DJIA 18,030.21 6.04 0.03%
NASDAQ 4,773.47 8.05 0.17%
S&P 500 2,081.88 -0.29 -0.01%
market minute promo

114.92 -1.18 (-1.02%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SLXP $114.92 -1.02%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.97
Previous Close $116.10
Daily Range $114.00 - $117.02
52-Week Range $86.00 - $172.98
Market Cap $7.3B
P/E Ratio -92.14
Dividend (Yield) $0.00 (0.0%)
Volume 324,700
Average Daily Volume 2,316,799
Current FY EPS -$1.97

Sector

Healthcare

Industry

Drugs

Salix Pharmaceuticals, Ltd. (SLXP) Description

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract. Website: http://www.salix.com/

News & Commentary

Why Salix Pharmaceuticals, Ltd. Stock Was Clobbered in November

Salix Pharmaceuticals gets clobbered in November after the integrity of its management team is called into question following its third-quarter earnings results.

Benzinga's M&A Chatter for Thursday December 18, 2014

Credit Suisse Raises Salix Pharmaceuticals Price Target

Salix Gains on Destocking Initiatives, Gives 2-Year Outlook - Analyst Blog

#PreMarket Movers From December 16, 2014

Can Salix Pharmaceuticals (SLXP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tap

Can Salix Pharmaceuticals (SLXP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

Ironwood Pharmaceuticals Advances IW-9179 to Phase IIa - Analyst Blog

Pharmaceutical Giant Merck Buys Cubist Pharma

Sterne Agee Says Salix Pharmaceuticals Accounting Concerns Are 'Overdone'

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

See More SLXP News...

SLXP's Top Competitors

SLXP $114.92 (-1.02%)
Current stock: SLXP
JNJ $104.59 (0.30%)
Current stock: JNJ
NVS $93.91 (0.71%)
Current stock: NVS
RHHBY $34.28 (-0.03%)
Current stock: RHHBY